1. Therapeutic applications of AS1411 aptamer, an update review.
- Author
-
Yazdian-Robati, Rezvan, Bayat, Payam, Oroojalian, Fatemeh, Zargari, Mehryar, Ramezani, Mohammad, Taghdisi, Seyed Mohammad, and Abnous, Khalil
- Subjects
- *
APTAMERS , *NUCLEOLIN , *PHOSPHOPROTEINS , *CELL membranes , *CELL growth , *TUMOR growth - Abstract
Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus. However, in several cancers, nucleolin is highly expressed both intracellularly and on the cell surface. So, it is considered as a potential target for the diagnosis and cancer therapy. Targeting nucleolin by compounds such as AS1411 aptamer can reduce tumor cell growth. In this regard, interest has increased in nucleolin as a molecular target for overcoming cancer therapy challenges. This review paper addressed recent progresses in nucleolin targeting by the G-rich AS1411 aptamer in the field of cancer therapy mainly over the past three years. • Nucleolin is highly expressed both intracellularly and on the cell surface. • It is considered as a potential target for the cancer diagnosis and therapy. • AS1411 a 26-mer DNA aptamer that binds nucleolin. • This review paper addressed recent progresses in nucleolin targeting by the AS1411. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF